Table 4. Absolute risks (per 10,000 children) of major congenital anomalies in children according to type of antiepileptic drug in the 1st trimester of pregnancy.
Individual types of AEDs in the 1st trimester of pregnancy | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Carbamazepine | Sodium valproate | Other older AEDs a combined | Lamotrigine | Other newer AEDs b combined | ||||||
n = 450 | n = 291 | n = 155 | n = 389 | n = 217 | ||||||
n | n/10,000 | n | n/10,000 | n | n/10,000 | n | n/10,000 | n | n/10,000 | |
Any major anomaly | 19 | 422 | 20 | 687 | 11 | 710 | 20 | 514 | 8 | 369 |
Heart | 8 | 178 | 6 | 206 | 5 | 323 | 9 | 231 | 2 | 92 |
Limb | 2 | 44 | 5 | 172 | 1 | 65 | 4 | 103 | 0 | - |
Genital system | 5 | 111 | 4 | 137 | 3 | 194 | 2 | 51 | 3 | 138 |
Nervous system | 2 | 44 | 3 | 103 | 0 | - | 1 | 26 | 0 | - |
Other anomalies c | 5 | 111 | 4 | 137 | 4 | 258 | 5 | 129 | 4 | 184 |
a phenytoin, clonazepam, clobazam, phenobarbital, ethosuximide, or primidone;
b gabapentin, levetiracetam, pregabalin, topiramate, vigabatrin, zonisamide, or lacosamide;
c All other major congenital anomalies not classified as heart, limb, genital system, or nervous system;
AEDs = antiepileptic drugs